Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Microsoft Corp. €403.10 €506.83
Amazon.com Inc. €235.45 €257.10
Schlumberger Ltd. €43.01 €52.02
Security Price Target price
Clorox Co. €82.86 €86.92
Western Union Co. €5.51 -
Jetblue Airways Corp. €4.99 €3.44

sharewise BeanCounterBot AI-generated

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2026-07-26

Financial analysis of Allergan

Enact Holdings (ACT) – FY2025 Annual Report

Enact appears to have closed FY2025 in a stable but slightly softer profitability position. Revenue reached roughly $1.24 billion, up modestly from the prior year, while net income of $674 million came in below FY2024's $688 million. The most striking contrast lies not in the operating results but in the stock's valuation: the price-to-earnings multiple appears to have tripled to around 40x, driven by a share price that climbed from roughly $59 to $181 over the year, even as earnings edged lower.

The revenue picture reflects a business whose core premium base has essentially plateaued—premiums earned barely moved year over year—while net investment income has become an increasingly meaningful contributor, rising to $266 million. What stands out most on the profitability side is the sharp increase in losses incurred, which nearly tripled to roughly $110 million. This jump, combined with a growing claims reserve, may suggest a normalization of credit conditions after several unusually benign years, and it appears to be the primary reason margins have continued to compress from the mid-60s percent range in 2022 toward the mid-50s today.

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

D-wave Quantum Inc.
Total
€941,131
Cash
€1,531.1
Performance (%)
841.131%

Pros and Cons of these stocks (New Predictions)

Bioage Labs Inc.

WKN: A40D7P / Name: Bioage Labs Inc. / Stock / ? /

Pros
1
Revenue growth >5% per year expected
1
EBIT growth >5% per year expected
1
Higher EBIT margin than peer group
Cons
1
Low dividend yield expected
1
negative Cash Flow expected
1
ROE lower than 10% per year
Replimune Group Inc

WKN: A2JQN1 / Symbol: REPL / Name: Replimune Group / Stock / Small Cap /

Pros
6
Could be worthwhile Investment >10% per year
Cons
3
Few uniques
1
Dependend from some customers or products
1
Growths slower than the competition
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Amazon.com Inc. €235.45 15.180%
Dexcom Inc. €72.40 11.730%
Newell Rubbermaid €4.84 9.300%
Monolithic Power Systems €1,236.0 8.620%
Flowserve Corp. €65.14 7.140%
Security Price Change(%) (%)
Western Union Co. €5.51 -16.740%
Godaddy Inc €71.76 -15.130%
Coinbase Global Inc. €126.72 -10.510%
Corteva Inc. €68.26 -10.220%
FMC Corp. €9.29 -9.600%

Courses

Get started on the stock market in these easy steps
This course is directed at beginners who want to get started on the stock market.

Things you will learn:
  •  What is a stock
  •  What is a fund
  •  What is an ETF
  •  How to open a depot
  •  How to manage a depot that will regularly beat managed funds
  •  Why you mostly need patience to succeed on the stock market

sharewise Introduction:
sharewise Introduction
This is a course about the functionalities of sharewise. You will learn about the basics and how to best use the platform.

Predictions

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€144.65
31.07.26
€216.33
31.07.27
-
31.07.26

buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€4.94
31.07.26
€16.51
31.07.27
-
30.07.26

buy
Carvana Co.

Start price
Target price
Perf. (%)
€54.09
31.07.26
€78.19
31.07.27
-
31.07.26

buy
Norwegian Cruise Line Hl.

Start price
Target price
Perf. (%)
€16.06
31.07.26
€19.11
31.07.27
-
31.07.26

Top News

News

Ranpak Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Specialty food store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/7a8f69d5-c26e-46d9-b403-d3e5e9562eca.png
Ranpak Q2 Earnings Call Highlights

Key Points

Olin Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
Olin Q2 Earnings Call Highlights

Key Points

Oil States International Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
Oil States International Q2 Earnings Call Highlights

Key Points

Omega Healthcare Investors Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
Omega Healthcare Investors Q2 Earnings Call Highlights

Key Points

Jabil (JBL) Beats Stock Market Upswing: What Investors Need to Know
Jabil (JBL) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Jabil (JBL) closed at $315.05, marking a +2.12% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.7%. Elsewhere, the Dow

PagSeguro Digital Ltd. (PAGS) Stock Sinks As Market Gains: Here's Why
PagSeguro Digital Ltd. (PAGS) Stock Sinks As Market Gains: Here's Why

In the latest close session, PagSeguro Digital Ltd. (PAGS) was down 2.03% at $9.64. The stock fell short of the S&P 500, which registered a gain of 0.7% for the day. On the other hand, the Dow

Lyft (LYFT) Exceeds Market Returns: Some Facts to Consider
Lyft (LYFT) Exceeds Market Returns: Some Facts to Consider

Lyft (LYFT) closed at $15.86 in the latest trading session, marking a +1.99% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.7%. Elsewhere, the Dow saw an upswing of 0.53%

Griffon (GFF) Stock Sinks As Market Gains: What You Should Know
Griffon (GFF) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Griffon (GFF) closed at $86.17, marking a -1.97% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.7% for the day

NatWest Group Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
NatWest Group Q2 Earnings Call Highlights

Key Points

Contest

Compete in Catch the Monkey ...

... and win a prize!

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren